武汉云克隆科技股份有限公司

可溶性半乳糖凝集素3结合蛋白(LGALS3BP)抗体对

Antibody Pair for Lectin Galactoside Binding, Soluble 3 Binding Protein (LGALS3BP)

MAC-2-BP; LGALS3-BP; Galectin-3-Binding Protein; L3 Antigen; Mac-2-Binding Protein; Tumor-associated antigen 90K; Serum Protein 90K; Basement membrane autoantigen p105

  • 可溶性半乳糖凝集素3结合蛋白(LGALS3BP)抗体对产品包装(模拟)
  • 可溶性半乳糖凝集素3结合蛋白(LGALS3BP)抗体对产品包装(模拟)
  • Certificate通过ISO 9001、ISO 13485质量体系认证

配对实验

用法

储存

避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。

相关产品

编号适用物种：Homo sapiens (Human，人)应用(仅供研究使用，不用于临床诊断！)
RPB766Hu01可溶性半乳糖凝集素3结合蛋白(LGALS3BP)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAB766Hu01可溶性半乳糖凝集素3结合蛋白(LGALS3BP)多克隆抗体WB; IHC; ICC; IP.
MAB766Hu22可溶性半乳糖凝集素3结合蛋白(LGALS3BP)单克隆抗体WB; IHC; ICC; IP.
MAB766Hu21可溶性半乳糖凝集素3结合蛋白(LGALS3BP)单克隆抗体WB,IHC
FAB766Hu02抗可溶性半乳糖凝集素3结合蛋白(LGALS3BP)单克隆抗体Flow cytometry.
FAB766Hu04抗可溶性半乳糖凝集素3结合蛋白(LGALS3BP)单克隆抗体Flow cytometry.
FAB766Hu06抗可溶性半乳糖凝集素3结合蛋白(LGALS3BP)单克隆抗体Flow cytometry.
FAB766Hu08抗可溶性半乳糖凝集素3结合蛋白(LGALS3BP)单克隆抗体Flow cytometry.
LAB766Hu72可溶性半乳糖凝集素3结合蛋白(LGALS3BP)单克隆抗体(生物素标记)WB; IHC; ICC.
SEB766Hu可溶性半乳糖凝集素3结合蛋白(LGALS3BP)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMB766Hu可溶性半乳糖凝集素3结合蛋白(LGALS3BP)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.
PSB766Hu01可溶性半乳糖凝集素3结合蛋白(LGALS3BP)抗体对ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSB766Hu01可溶性半乳糖凝集素3结合蛋白(LGALS3BP)检测试剂盒DIY材料(酶联免疫吸附试验法)Main materials for "Do It (ELISA Kit) Yourself".

参考文献

杂志参考文献
AndrologyComparative proteomic analysis coupled with conventional protein assay as a strategy to identify predictors of successful testicular sperm extraction in patients with non-obstructive azoospermia[PubMed: 23427166]
Liver InternationalIdentification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 4-D DIGE[Pubmed: 23944848]
Acta Anaesthesiologica ScandinavicaEarly prognostic factors in septic shock cancer patients: a prospective study with a proteomic approach[Pubmed:29315472]